Methyl 3-hydroxymethyl-1-methyl-1H-pyrazole-5-carboxylate, 95.0%, 250mg

(R)-Butane-1,2-diol, 95.0%, 100g

2-Bromo-3-iodotoluene, 98.0%, 250mg

2-Bromo-3,5-dimethyl-benzoic acid, 95.0%, 10g

3,4-Ethylenedioxythiophene-2-carboxaldehyde>98.0%(GC)5g

tert-Butyl 2-amino-4-oxo-3,5,7,8-tetrahydropyrido[4,3-d]pyrimidine-6(4H)-carboxylate, 97%, 250mg

(S)-9,10-Difluoro-3-methyl-7-oxo-3,7-dihydro-2H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid, 95.0%, 10g

(4S,4'S)-2,2'-(2-(4-(tert-Butyl)phenyl)ethane-1,1-diyl)bis(4-(tert-butyl)-4,5-dihydrooxazole), 97%, 100mg

Phenyl 2,3,4,6-Tetra-O-benzyl-1-thio-beta-D-galactopyranoside>98.0%(HPLC)1g

trans,trans-4-(3,4-Difluorophenyl)-4'-pentyl-1,1'-bi(cyclohexane), 97%, 10g

Sal disódica del ácido etilendiaminotetraacético dihidrato, 2,5 kg

(6-Chloro-pyridazin-3-yl)-(4-methoxy-phenyl)-acetonitrile, 95.0%, 1g

Rociletinib, 99%, 10mg